June 24, 2020

Consolidated Financial Results
for the Fiscal Year Ended March 31, 2020
(Japanese Accounting Standards)
Name of the Listed Company:
Listing:
Stock code:
URL:
Representative:
Contact Person:

Nitta Gelatin Inc.

First Section of Tokyo Stock Exchange4977
http://www.nitta-gelatin.co.jp
Koichi Ogata, Representative Director and President
Norifumi Nagaoka, Director and Executive Officer;
General Manager of General Management Division
Tel: +81-72-949-5381
Scheduled date of General Shareholders’ Meeting: June 25, 2020
Scheduled date to file Securities Report:
July 31, 2020
Scheduled date to commence dividend payments: June 26, 2020
Supplementary explanatory materials prepared:
Yes
Explanatory meeting:
No(Millions of yen with fractional amounts discarded, unless otherwise noted.)

1. Consolidated financial results for the fiscal year ended March 31, 2020
(from April 1, 2019 to March 31, 2020)(1) Consolidated operating results(Percentages indicate year-on-year changes.)

Net sales

Fiscal year ended
March 31, 2020
March 31, 2019

Millions of yen

Operating income%

Millions of yen

34,543(5.3)
1,690
36,464(3.5)
898
Note: Comprehensive income
For the year ended March 31, 2020: ¥60 million (87.7%)
For the year ended March 31, 2019: ¥495 million (-%)
Net income
per share

Fiscal year ended
March 31, 2020
March 31, 2019%

Millions of yen

88.2(17.9)

1,798
828

Diluted net income Return on equity
per share
(ROE)

Yen

(37.79)53.85
Reference : Equity in earnings of affiliates
For the year ended March 31, 2020:
For the year ended March 31, 2019:

Yen-

Net income
attributable to ownersof the parent

Ordinary income
%

(694)
989

Ordinary income/ Total assets

%

(4.4)
6.3

Millions of yen

117.1(15.4)

Operatingmargin%5.0
2.2¥155 million¥(132 million)

Notes: Diluted net income per share is not disclosed due to the absence of latent shares with dilution effect.

%

-

%

4.9
2.5

(2) Consolidated financial position
Total assets

As ofMarch 31, 2020
March 31, 2019

Net assets

Equity ratio

Millions of yen

Millions of yen

33,551
37,715

17,461
17,708Reference: Equity
As of March 31, 2020:
As of March 31, 2019:

Net assets per share
%

Yen

46.7
42.0

852.71862.29Net cash provided by(used in) financing
activities

Cash andcash equivalents
at end of year

¥15,667 million¥15,843 million(3) Consolidated cash flows
Net cash provided byoperating activities

Fiscal year ended
March 31, 2020
March 31, 2019

Net cash used ininvesting activities

Millions of yen

Millions of yen

1,969
2,232

(889)
(708)

Millions of yen

Millions of yen(1,739)(1,009)

1,381
2,051

2. Cash dividendsFirstquarter

Secondquarter

Third
quarter

Fiscalyear-end

AnnualTotal amountof dividends(annual)

Yen

Yen

Yen

Yen

Yen

Millions of yen

Cash dividends per share

Payout ratio(consolidated)

Dividends on
net assets(consolidated)%%

Fiscal year ended
6.00
10.00
16.00
293
29.7
1.9
March 31, 2019
Fiscal year ended
6.00
6.00
12.00
(31.8)
1.4
220
March 31, 2020
Fiscal year ending
6.00
6.00
12.00
March 31, 2021
27.1
(Forecasts)
Note: Breakdown of fiscal year-end dividend for the fiscal year ended March 31, 2019: ¥6.00 in ordinary dividend and ¥4.00
in commemorative dividend per share

3. Consolidated financial forecasts for the fiscal year ending March 31, 2021
(from April 1, 2020 to March 31, 2021)

OperatingincomeNet sales

Six months ending
September 30, 2020
Fiscal year ending
March 31, 2021

(Percentages indicate year-on-year changes.)
Net income
Net income
attributable toOrdinary income
owners of theper share
parentMillionsof yen%Millionsof yen%Millionsof yen%Millionsof yen15,500(16.8)

600(29.1)

600(38.8)

500(23.6)

27.66

31,500

(8.8)

1,300

(23.1)

1,200(33.3)

800

-

44.26

%

Yen

Notes:(1) Changes in significant subsidiaries during the period (changes in specified subsidiaries resulting in achange in the scope of consolidation): Yes
New:
None
Excluded: Two companies; Company name: Nitta Casings Inc. andPackage Hongkong Limited

(2) Changes in accounting policies, changes in accounting estimates, and restatement of revisions
a. Changes in accounting policies due to revisions to accounting standards and other guidelines: Yes
b. Changes in accounting policies due to reasons other than a. above: No
c. Changes in accounting estimates: No
d. Restatement of revisions: No
Note: For details, please refer to “(6) Notes to Consolidated Financial Statements (Changes in Accounting

Policies) in “3. Consolidated Financial Statements and Key Notes” on page 15 of the Attachment to thisreport.

(3) Number of common shares issued
a. Total number of issued shares at the end of the period (including treasury stock)
As of March 31, 2020 18,373,974 shares
As of March 31, 2019 18,373,974 sharesb. Number of shares of treasury stock at the end of the period
As of March 31, 2020 167 shares
As of March 31, 2019 163 sharesc. Average number of shares
For the year ended March 31, 2020
For the year ended March 31, 201918,373,810 shares
18,373,812 shares(Reference) Summary of non-consolidated operating results
1. Non-consolidated financial results for the fiscal year ended March 31, 2020
(from April 1, 2019 to March 31, 2020)(1) Non-consolidated operating results(Percentages indicate year-on-year changes)
Net sales

Operating income

Ordinary income

Net income

Fiscal year ended
March 31, 2020

Millions of yen

22,240

(0.3)

851

169.1

1,168

17.1

62

(93.8)March 31, 2019

22,311(3.9)

316(63.4)

997

(4.0)

1,005

-

%

Net income
per share

Millions of yen%

Millions of yen%

Millions of yen%

Diluted net income
per share

Fiscal year ended
March 31, 2020

3.41

-

March 31, 2019

54.72

-

Yen

Yen

Note: Diluted net income per share is not disclosed due to the absence of latent shares with dilution effect.

(2) Non-consolidated financial position
Total assets

Net assets

Equity ratio

Net assets per share
Yen

As of
March 31, 2020

Millions of yen

Millions of yen

24,847

13,09852.7

712.87

March 31, 2019

26,597

13,68251.4

744.65

Reference: Equity
As of March 31, 2020: ¥13,098 million
As of March 31, 2019: ¥13,682 million%

* This financial report is not subject to audits by Certified Public Accountants or the independent auditor.
* Proper use of earnings forecasts, and other special matters
The forward-looking statements, including earnings forecasts, contained in these materials are based on
information currently available to the Company and on certain assumptions deemed to be reasonable. Thesestatements do not guarantee that the Company will achieve its earnings forecasts. In addition, actual businessand other results may differ substantially due to various factors. For details on the conditions assumed and thecautionary notes and items in the financial forecasts, please refer to “(4) Outlook” under “1. Overview ofBusiness Results” on page 5 of the Attachment to this report.
(How to obtain supplementary financial results explanatory materials)
Supplementary financial results explanatory materials are scheduled to be made available on the Company’s website
on July 10, 2020.

Attachment Contents
1. Overview of Business Results ····················································································· 2(1) Operating Results for the fiscal year ended March 31, 2019 ················································ 2(2) Financial Position ································································································· 3(3) Cash Flows ········································································································ 4(4) Outlook ············································································································· 5
2. Basic Approach to Selection of Accounting Standard ······················································· 6
3. Consolidated Financial Statements and Key Notes ··························································· 7(1) Consolidated Balance Sheets ···················································································· 7(2) Consolidated Statements of Income and Consolidated Statements of Comprehensive Income ········ 9Consolidated Statements of Income ············································································ 9Consolidated Statements of Comprehensive Income ······················································ 10(3) Consolidated Statements of Changes in Net Assets ·························································11(4) Consolidated Statements of Cash Flows ····································································· 13(5) Additional Information ························································································· 14(6) Notes to Consolidated Financial Statements ································································ 14(Note Concerning Going Concern Assumption) ··························································· 14(Changes in Accounting Policies) ············································································ 14(Accounting Standards, etc. Yet to Be Applied) ···························································· 15(Changes in Presentation Basis) ··············································································· 17(Business Combinations) ······················································································ 18(Segment Information) ························································································· 21(Per Share Information) ························································································ 22(Subsequent Events) ···························································································· 23

11. Overview of Business Results(1) Operating Results for the fiscal year ended March 31, 2020
In the fiscal year ended March 31, 2020, the global economy had been recovering at a moderate pace,but business conditions started to deteriorate rapidly from the beginning of 2020 due to the global
spread of coronavirus disease 2019 (COVID-19). The Japanese economy also saw stagnant social andeconomic activity due to measures undertaken to prevent the widening COVID-19 outbreak, in
addition to deterioration in the global economy. Consequently, the outlook has become very
challenging.
In this environment, the Nitta Gelatin Group will implement the following management policies
under the Medium-Term Management Plan running through the fiscal year ending March 31, 2021:
1. Our three core areas will be food solutions, health support, and biomedical.
2. We will globally optimize our production system in Japan, Asia, and North America
in response to an era of completely free trade.
3. We will promote selection and concentration and create high-value-added products and services
to recreate the Company as a higher-profit enterprise.
Guided by these management policies, the Group actively worked on research and development ofhigh-value-added products, growth in sales of new products and development of new markets in its
three core areas. As part of these efforts, the Group focused on sponsoring and distributing products at
various running events for the purpose of promoting its new products for the sports nutrition market. It
also focused on implementing programs to raise awareness of collagen peptide’s functionality throughsuch means as holding symposiums. The Group strove to enhance productivity and reduce costs ateach of its manufacturing sites.
Moreover, based on a policy of selection and concentration, the Group excluded Nitta Casings Inc.,a former specified subsidiary of the Company, and Nitta Casings (CANADA) Inc., from the scope of
consolidation in connection with the transfer of all shares of these two companies in December 2019.
As a result, in the fiscal year ended March 31, 2020, net sales decreased 5.3% year on year to¥34,543 million. However, operating income rose 88.2% to ¥1,690 million mainly due to pricerevisions, improved productivity and cost reductions. Ordinary income increased 117.1% to ¥1,798
million, mainly due to the recording of increases in items such as equity in earnings of affiliates.
Meanwhile, the Group recorded a net loss attributable to owners of the parent of ¥694 million(compared with net income attributable to owners of the parent of ¥989 million in the previous fiscal
year). The net loss reflected the recording of items such as a loss on sales of stocks of subsidiaries andassociates of ¥2,788 million in connection with the transfer of shares.
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,
but an overview of the performance of each sales category is as follows:2

(Food solutions)
In Japan, sales for use in confectionery rose as the market for gummy candy remained firm, mainly
because of the launch of new products by customers. Sales for use in delicatessen items for convenience
stores increased owing to efforts to expand sales, in addition to firm demand for ready-made meals
against the backdrop of an increase in single-person households. In products for the HORECA market,
sales increased as the launch of new products and efforts to expand sales led to solid results.
Overseas, sales to the markets for gummy candy, jelly confectionery and other applications rose in
the North America region. Meanwhile, sales of collagen casings decreased due to exclusion from thescope of consolidation.
As a result, overall sales in the food solutions category decreased 12.6% year on year to ¥14,394
million.
(Health support)
In Japan, sales of collagen peptide products for beauty supplement applications increased, as a result offirm demand from main customers, as well as the implementation of price revisions. Meanwhile, salesof capsules declined, mainly due to the impact of a decrease in demand from inbound tourists visiting
Japan from abroad.
Overseas, the North America region saw increased sales, due in part to firm demand for capsules forhealth foods, in addition to higher sales driven by growth in the collagen peptide markets for health andbeauty applications. In the Asian region, net sales increased owing to proactive efforts to expand sales in
the collagen peptide market, solid demand for capsules for pharmaceutical and health food applicationsin India, and firm demand for collagen peptide for health food applications.
As a result, overall sales in the health support category increased 6.4% year on year to ¥14,270
million.
(Specialties)
In adhesives, overall sales decreased 10.8% year on year to ¥5,879 million, influenced by a sales pricechange in adhesives and declining sales in adhesives for hygiene products.

(2) Financial Position
Changes in assets, liabilities, and net assets at March 31, 2020 mainly include the impact of the
exclusion of Nitta Casings Inc. and Nitta Casings (CANADA) Inc. from the scope of consolidation.
(Assets)
Total assets amounted to ¥33,551 million at March 31, 2020, ¥4,164 million lower than at March 31,
2019. This was mainly attributable to decreases in cash and deposits of ¥677 million, notes andaccounts receivable-trade of ¥911 million, buildings and structures, net of ¥434 million, machinery,equipment and vehicles, net of ¥1,869 million, and investment securities of ¥376 million.

3

(Liabilities)
Total liabilities stood at ¥16,090 million at March 31, 2020, ¥3,916 million lower than at March 31,
2019. This was mainly attributable to decreases in notes and accounts payable-trade of ¥1,177 million,
short-term loans payable of ¥812 million, long-term loans payable of ¥775 million, and net defined
benefit liability of ¥1,084 million.
(Net assets)
Net assets amounted to ¥17,461 million at March 31, 2020, ¥247 million lower than at March 31, 2019.
This was mainly due to decreases in retained earnings of ¥988 million, valuation difference on otheravailable-for-sale securities of ¥354 million, and foreign currency translation adjustments of ¥521
million, which was partly offset by an increase in remeasurements of defined benefit plans of ¥1,726
million.
As a result, the equity ratio stood at 46.7% at March 31, 2020 compared with 42.0% at March 31,
2019.

(3) Cash Flows
Cash and cash equivalents (“cash”) as of March 31, 2020 was ¥1,381 million, down ¥670 million fromMarch 31, 2019.
Cash flows for each activity and reasons are as follows.
(Net cash provided by operating activities)
Operating activities provided net cash of ¥1,969 million. The main components were loss before
provision of income taxes of ¥943 million, depreciation and amortization of ¥1,448 million, increase ininventories of ¥627 million, decrease in notes and accounts payable-trade of ¥633 million and loss on
sales of shares of subsidiaries and associates of ¥2,782 million.
(Net cash used in investing activities)
Investing activities used net cash of ¥889 million. This was mainly attributable to ¥900 million inpurchase of property, plant and equipment.
(Net cash used in financing activities)
Financing activities used net cash of ¥1,739 million. The main uses of cash were net decrease in
short-term loans payable of ¥667 million, repayment of long-term loans payable of ¥1,990 million, andcash dividends paid of ¥293 million, which were partially offset by proceeds from long-term loans
payable of ¥1,200 million.

4

(Reference)
Trends in cash flow indicators are as shown below:
Fiscal year ended

Fiscal year ended

Fiscal year ended

Fiscal year ended

Fiscal year ended

March 31, 2016

March 31, 2017

March 31, 2018

March 31, 2019

March 31, 2020

Equity ratio (%)

39.8

38.9

40.7

42.0

46.7

Market value equity ratio (%)

35.9

34.3

39.3

33.4

32.4

Interest-bearing debt to cash
flow ratio (Years)

4.4

5.9

7.2

4.3

4.1

Interest coverage ratio (Times)

7.6

8.1

6.0

9.2

10.4

Equity ratio: equity / total assets
Market value equity ratio: market capitalization / total assets
Interest-bearing debt to cash flow ratio: interest-bearing debt / cash flow
Interest coverage ratio: cash flow / paid interest
Notes: 1. All indicators are calculated using consolidated financial figures.
2. Market capitalization is calculated based on the number of issued shares, excluding treasury stock,
as of the end of the fiscal year.
3. The figure used for cash flow is “net cash provided by operating activities” on the consolidated
statements of cash flows.
4. Interest-bearing debt includes all liabilities recorded on the consolidated balance sheets on whichinterest was paid. Furthermore, regarding the paid interest, we use “interest expenses paid” recordedon the consolidated statements of cash flows.

(4) Outlook(Outlook for Business Performance in the Fiscal Year Ending March 31, 2021)
The global economy is not expected to see an end to the worldwide COVID-19 pandemic at this time.
Accordingly, we will need to adapt to a “new normal in daily life,” as we remain mindful of the needto coexist with the coronavirus.
Under these conditions, the Group will continue to pursue the enormous potential of collagen as aunique natural material, in order to supply products and services that address its customers’ “newnormal in daily life.” Moreover, the Group will develop products that take full advantage of its
research accomplishments in the fields of collagen and collagen peptide. By doing so, the Group will
help to fulfill the desire of its customers “To stay healthy and feeling young,” as laid out in its vision.
It is difficult to reasonably estimate the impact of COVID-19 on the Group’s outlook for businessperformance at this time. However, demand for gelatin for capsules and collagen peptide forpromoting better health is forecast to remain firm both in Japan and overseas. Meanwhile, products for
the HORECA market, which includes hotels and restaurants, could be impacted substantially by thecontinuation of stay-at-home requests and restrictions on movement for tourism purposes. Even inthese circumstances, the Group will continue working to ensure the stable supply of products by
striving to diversify its suppliers and reduce production costs.
With regard to capital investment, in Japan the Group will look to increase product quality andinvest in raising operating efficiency as well as equipment for research and development. Overseas, theGroup will execute investments aimed at equipment and facilities that enhance productivity as well as
5measures to address environmental conservation.
Forecast for Consolidated Financial Results for the Next Fiscal Year
Consolidated financial
forecasts for the fiscal year
ending March 31, 2021

Year on year change(Millions of yen)(%)

Net sales

31,500(8.8)

Operating income

1,300(23.1)

Ordinary income
Net income attributableto owners of the parent

1,200(33.3)

800—(Risks related to COVID-19)
In order to prevent the spread of COVID-19, the Group believes that securing the safety of its business
partners and employees is a top priority. Accordingly, the Group is working to develop telework andflexible work arrangements, and to proactively adopt web conferences, in order to help its business
partners and employees avoid the so-called three Cs: closed spaces, crowded places, and close-contact
settings. However, COVID-19 could still impact the Group’s business performance and financial
position through contingencies such as a deterioration in raw material procurement conditions, theimpact of the infection of employees on the production system, and restrictions on economic activity atoverseas business sites.

2. Basic Approach to Selection of Accounting Standard
The Nitta Gelatin Group plans to prepare its consolidated financial statements based on Japanese
accounting standards in the near future. This is in consideration of the need to ensure that theconsolidated financial statements can be readily compared between different periods and different
companies.
Looking ahead, considering its management policies and various conditions in Japan and abroad,
Nitta Gelatin plans to examine the adoption of International Financial Reporting Standards (IFRS). In
doing so, the Group will take into account trends such as the adoption of IFRS by its peer companies.

63. Consolidated Financial Statements and Key Notes(1) Consolidated Balance Sheets(Millions of yen)

AssetsCurrent assets
Cash and deposits
Notes and accounts receivable-trade
Merchandise and finished goods
Work in process
Raw materials and supplies
Other
Allowance for doubtful accounts
Total current assets
Noncurrent assets
Property, plant and equipment
Buildings and structures
Accumulated depreciation
Buildings and structures, net
Machinery, equipment and vehicles
Accumulated depreciation
Machinery, equipment and vehicles, net
Land
Lease assets
Accumulated depreciation
Lease assets, net
Construction in process
Other
Accumulated depreciation
Other, net
Total property, plant and equipment
Intangible assets
Goodwill
Other
Total intangible assets
Investments and other assets
Investment securities
Long-term loans receivable
Deferred tax assets
Net defined benefit asset
Other
Allowance for doubtful accounts
Total investments and other assets
Total noncurrent assets
Total assets

7

Fiscal 2019

Fiscal 2020

(As of March 31, 2019)(As of March 31, 2020)

2,092
8,589
5,884
1,350
2,911
558
(9)
21,378

1,414
7,677
5,674
1,284
2,786
499
(15)
19,322

10,660(6,871)
3,788
17,514(12,865)
4,648
2,166
948
(453)
494
184
1,383
(1,115)268
11,551

8,943(5,589)3,354
13,327(10,547)
2,779
2,111
1,003
(443)
559
119
1,399
(1,141)
258
9,183

353
231
585

300
220
521

3,260
138
152
572
270
(193)
4,200
16,33737,715

2,883
101
762
531
352
(105)
4,524
14,22933,551

(Millions of yen)

Liabilities
Current liabilities
Notes and accounts payable-trade
Short-term loans payable
Current portion of long-term loans payable
Lease obligations
Accounts payable-other
Income taxes payable
Provision for bonuses
Other
Total current liabilities
Noncurrent liabilities
Long-term loans payable
Lease obligations
Deferred tax liabilities
Net defined benefit liability
Total noncurrent liabilities
Total liabilities
Net Assets
Shareholders’ equity
Capital stock
Capital surplus
Retained earnings
Treasury stock
Total shareholders’ equity
Accumulated other comprehensive income (loss)
Valuation difference on other available-for-sale securities
Deferred gains (losses) on hedges
Foreign currency translation adjustments
Remeasurements of defined benefit plans
Total accumulated other comprehensive loss
Non-controlling interests
Total net assets
Total liabilities and net assets

8

Fiscal 2019

Fiscal 2020

(As of March 31, 2019)(As of March 31, 2020)

4,794
2,657
2,386
196
1,614
237
205
468
12,559

3,617
1,844
2,358
199
1,697
107
219
628
10,672

4,000
343
371
2,731
7,447
20,007

3,225
415
129
1,647
5,417
16,0903,144
2,966
10,155(0)
16,266

3,144
2,966
9,166
(0)
15,278

1,274
(8)
174
(1,863)(423)
1,865
17,70837,715

920
(47)
(346)
(137)
389
1,793
17,461
33,551

(2) Consolidated Statements of Income and Consolidated Statements of Comprehensive Income(Consolidated Statements of Income)(Millions of yen)

Net sales
Cost of sales
Gross profit on sales
Selling, general and administrative expenses
Operating income
Non-operating income
Interest income
Dividend income
Rent income
Outsourcing service income
Foreign exchange gains
Equity in earnings of affiliates
Other
Total non-operating income
Non-operating expenses
Interest expenses
Foreign exchange losses
Equity in losses of affiliates
Commissions paid
Other
Total non-operating expenses
Ordinary income
Extraordinary gains
Gain on sales of noncurrent assets
Reversal of allowance for doubtful accounts
Gain on sales of stocks of subsidiaries and associates
Subsidy income
Transfer gain on business divestiture
Gain on change in equity
Total extraordinary gains
Extraordinary losses
Provision of allowance for doubtful accounts
Disposal costs for noncurrent assets
Loss on retirement of noncurrent assets
Loss on tax purpose reduction entry of noncurrent assets
Loss on sales of stocks of subsidiaries and associates
Loss on disaster
Impairment loss
Total extraordinary losses
Income (loss) before provision of income taxes
Income taxes
Income taxes-deferred
Total income taxes
Net income (loss)
Net income (loss) attributable to non-controlling interests
Net income (loss) attributable to owners of the parent

9

Fiscal 2019

Fiscal 2020

(From April 1, 2018
to March 31, 2019)(From April 1, 2019
to March 31, 2020)

36,46429,079
7,384
6,486
898

34,54327,244
7,299
5,608
1,690

10
39
47
32
119
69
317

6
43
42
53
－
155
40
341

236
－
132
9
9
387
828

187
9
－
26
10
233
1,798

81
－
－
147
655
416
1,301

17
29
6
－
－
－
53

127
3
171
147
－
13
634
1,098
1,031
431
(217)
214
817
(171)
989

－
1
5
－
2,788
－
－
2,796
(943)
40
(460)
(420)
(523)
170
(694)

(Consolidated Statements of Comprehensive Income)(Millions of yen)

Net income (loss)
Other comprehensive income
Valuation difference on other available-for-sale securities
Deferred gains (losses) on hedges
Foreign currency translation adjustments
Pension liability adjustment
Share of other comprehensive income of associates
accounted for using equity method
Total other comprehensive income
Total comprehensive income
Comprehensive income attributable to:
Owners of the parent
Non-controlling interests

10

Fiscal 2019

Fiscal 2020

(From April 1, 2018
to March 31, 2019)(From April 1, 2019
to March 31, 2020)

817

(523)

(57)
47
46
(306)

(354)
(89)
(702)
1,723

(52)

8

(321)
495

584
60

687
(191)

117
(57)

(3) Consolidated Statements of Changes in Net Assets
Fiscal 2019 (From April 1, 2018 to March 31, 2019)(Millions of yen)
Shareholders’ equity
Capital stock
Balance at the beginning of fiscal year
Changes during the fiscal year
Dividends from surplus
Net income (loss) attributable toowners of the parent
Purchase of treasury stock
Net changes of items other thanshareholders’ equity
Total changes during fiscal year
Balance at the end of fiscal year

Capital surplus

3,144

2,966

Retained earnings

Treasury stock

9,386

Total shareholders’equity(0)15,497

(220)

(220)

989

989
(0)

(0)
-

-

-

768

(0)

768

3,144

2,966

10,155(0)

16,266

Noncontrollinginterests

Total
net assets

2,082

17,459

Accumulated other comprehensive income
Valuationdifference on
available-forsale securities

Balance at the beginning of fiscal year
Changes during the fiscal year
Dividends from surplus
Net income (loss) attributable toowners of the parent
Purchase of treasury stock
Net changes of items other thanshareholders’ equity
Total changes during fiscal year
Balance at the end of fiscal year

Deferred gains(losses) onhedges1,331

Foreigncurrencytranslation
adjustment

(43)

149

Remeasurements ofdefined benefit
plans

Total accumulated othercomprehensive
income(1,558)

(120)
-

(220)

-

989

-

(0)

(57)

35

25

(305)

(302)

(216)

(519)

(57)
1,274

35
(8)

25
174

(305)
(1,863)

(302)
(423)

(216)
1,865

249
17,708

Fiscal 2020 (From April 1, 2019 to March 31, 2020)(Millions of yen)
Shareholders’ equity
Capital stock
Balance at the beginning of fiscal year
Changes during the fiscal year
Dividends from surplus
Net income (loss) attributable toowners of the parent
Purchase of treasury stock
Net changes of items other thanshareholders’ equity
Total changes during fiscal year
Balance at the end of fiscal year

Capital surplus

3,144

2,966

Retained earnings

Treasury stock

10,155

Total shareholders’equity(0)16,266

(293)

(293)

(694)

(694)
(0)

(0)
-

-

-

(988)

(0)

(988)

3,144

2,966

9,166

(0)

15,278

Noncontrollinginterests

Total
net assets

1,865

17,708

Accumulated other comprehensive income
Valuationdifference on
available-forsale securities

Balance at the beginning of fiscal year
Changes during the fiscal year
Dividends from surplus
Net income (loss) attributable toowners of the parent
Purchase of treasury stock
Net changes of items other thanshareholders’ equity
Total changes during fiscal year
Balance at the end of fiscal year

1,274

Deferred gains(losses) onhedgesForeigncurrencytranslation
adjustment

(8)

174

Remeasurements ofdefined benefit
plans

Total accumulated othercomprehensive
income(1,863)

(423)

-

(293)

-

(694)

-

(0)

(354)

(38)

(521)

1,726

812

(354)

(38)

(521)

1,726

812

(71)

(247)

920

(47)

(346)

(137)

389

1,793

17,461

11

(71)

740

(4) Consolidated Statements of Cash Flows(Millions of yen)

Cash flows from operating activities
Income before provision of income taxes
Depreciation and amortization
Amortization of goodwill
Increase (decrease) in allowance for doubtful accounts
Increase (decrease) in provision for bonuses
Increase (decrease) in net defined benefit liability
Interest and dividends income
Interest expenses
Foreign exchange losses (gains)
Equity in earnings of affiliates
Loss (gain) on sales of property, plant and equipment
Loss (gain) on retirement of noncurrent assets
Impairment loss
Loss (gain) on sales of investment securities
Loss (gain) on sales of stocks of subsidiaries and associates
Loss (gain) on change in equity
Loss (gain) on business divestiture
Loss on tax purpose reduction entry of noncurrent assets
Subsidy income
Loss on disaster
Decrease (increase) in notes and accounts receivable-trade
Decrease (increase) in inventories
Increase (decrease) in notes and accounts payable-trade
Increase (decrease) in accrued consumption taxes
Other, net
SubtotalInterest and dividends income received
Interest paid
Income taxes paid
Net cash provided by operating activities
Cash flows from investing activities
Payments into time deposits
Proceeds from withdrawal of time deposits
Proceeds from the sale of property, plant and equipment
Purchase of property, plant and equipment
Purchase of intangible assets
Subsidies received
Proceeds from the sale of investment securities
Purchase of investment securities
Proceeds from business divestiture
Payment of expenses related to business divesture
Proceeds from sales of shares of subsidiaries resulting inchangein scope of consolidation
Other, net
Net cash used in investing activities

12

Fiscal 2019

Fiscal 2020

(From April 1, 2018
to March 31, 2019)(From April 1, 2019
to March 31, 2020)

1,031
1,568
47
128
(47)
20
(49)
236
(99)
132
(78)
171
634

(943)
1,448
46
(17)
16
(72)
(49)
187
68
(155)
(16)
5
－
(2)
2,782
－
－
－
－
－
270
(627)
(633)
75
(71)
2,313
49
(189)
(204)
1,969

(416)
(655)
147
(147)
13
412
(753)
567
(158)
(221)
2,484
238
(237)
(252)
2,232
(21)
65
475
(1,967)
(19)
147
0
(7)
887
(180)
(89)
(708)

(11)
19
7
(900)
(38)
－
3
(7)
－
(114)
119
34
(889)

(Millions of yen)

Cash flows from financing activities
Net increase (decrease) in short-term loans payable
Proceeds from long-term loans payable
Repayment of long-term loans payable
Proceeds from sale-and-leaseback transactions
Repayments of lease obligations
Cash dividends paid
Purchase of treasury stock
Cash dividends paid to non-controlling interests
Net cash (used in) provided by financing activities
Effect of exchange rate change on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, beginning of the fiscal year
Cash and cash equivalents at end of the fiscal year

13

Fiscal 2019

Fiscal 2020

(From April 1, 2018
to March 31, 2019)(From April 1, 2019
to March 31, 2020)

118
1,800
(2,664)
195
(212)
(220)
（0）
(25)
(1,009)
(0)
513
1,538
2,051

(667)
1,200
(1,990)
260
(233)
(293)
（0）
(14)
(1,739)
(10)
(670)
2,051
1,381

(5) Additional Information(Impact of COVID-19)
The Group had made estimates for evaluating the recoverability of deferred tax assets in accordancewith business plans formulated based on information available as of the end of the fiscal year underreview.
Although it is difficult to foresee when COVID-19 will end, in the process of formulating businessplans, the Group has assumed that COVID-19 will start to subside sometime in the summer and it willstop having an impact on the Group by the next fiscal year.
The Group is likely to be impacted by COVID-19 through a projected decrease in sales of products
for the HORECA market, which includes hotels and restaurants, due to factors such as stay-at-homerequests. However, COVID-19 is not expected to have a large impact on gelatin for capsules andcollagen peptide for promoting better health, and demand for these products is forecast to remain firm
both in Japan and overseas(6) Notes to Consolidated Financial Statements(Note Concerning Going Concern Assumption)
None.
(Changes in Accounting Policies)(Application of IFRS 16 Leases)
The Nitta Gelatin Group has adopted IFRS 16 “Leases” for all overseas subsidiaries except thosein the U.S. from the beginning of the year ended March 31, 2020. As a transitional measure upon
the adoption of IFRS 16, the Group applies the standard, which recognizes the cumulative effectat the date of initial adoption.
As a result, the consolidated balance sheet as of March 31, 2020 shows increases of ¥6 million
in “Leased assets” under property, plant and equipment, ¥5 million in “Lease obligations” undercurrent liabilities, and ¥1 million in “Lease obligations” under noncurrent liabilities.
The effect of this change on the Company’s consolidated profit and loss for the year ended
March 31, 2020 is negligible.
(Proposed Amendments to Practical Solution on Unification of Accounting Policies Applied toForeign Subsidiaries, etc. for Consolidated Financial Statements)
The Group has adopted the revised PITF No.18 Practical Solution on Unification of Accounting
Policies Applied to Foreign Subsidiaries, etc. for Consolidated Financial Statements (revised June
28, 2019) and PITF No.24 Practical Solution on Unification of Accounting Policies Applied to
Associates Accounted for Using the Equity Method (revised September 14, 2018) from the
beginning of the year ended March 31, 2020. The effect of adopting these revised practicalsolutions on the Consolidated Financial Statements is negligible.

14(Accounting Standards, etc. Yet to Be Applied)(1) Revised Accounting Standard for Revenue Recognition, etc.
・ “Accounting Standard for Revenue Recognition (ASBJ Statement No. 29, March 31, 2020, ASBJ)・ “Implementation Guidance on Accounting Standard for Revenue Recognition” (ASBJ Guidance
No. 30, March 31, 2020, ASBJ)・ “Implementation Guidance on Disclosures about Fair Value of Financial Instruments” (ASBJ
Guidance No. 19, March 31, 2020, ASBJ)
a. Overview
The International Accounting Standards Board (IASB) and the Financial Accounting Standards
Board (FASB) in the United States jointly developed comprehensive standards for revenue
recognition and published the “Revenue from Contracts with Customers” (IFRS 15 at the IASB
and Topic 606 at the FASB) in May 2014. Given that IFRS 15 has been applied from fiscal years
starting on or after January 1, 2018 and that Topic 606 has been applied from fiscal years starting
after December 15, 2017, the Accounting Standards Board of Japan (ASBJ) has developed
comprehensive accounting standards for revenue recognition and published them together with
Implementation Guidance.
The basic policy of the ASBJ in developing accounting standards for revenue recognition is toset accounting standards, with the incorporation of the basic principles of IFRS 15 as a starting
point, from the standpoint of maintaining comparability between financial statements, which isone of the benefits of ensuring consistency with IFRS 15. The basic policy also calls for adding
alternative accounting treatments without compromising consistency with IFRS 15 if there are
any items that should require consideration of practices, etc. that have been carried out in Japan.

b. Planned date of application
To be applied from the beginning of the fiscal year ending March 31, 2022
c. Impact of the application of the accounting standards, etc.
The Group is currently in the process of determining the effects of applying the Revised
Accounting Standard for Revenue Recognition, etc. on the consolidated financial statements.
(2) Accounting Standards for Fair Value Measurement, etc.
・ “Accounting Standard for Fair Value Measurement” (ASBJ Statement No. 30, July 4, 2019,
ASBJ)
・ “Accounting Standard for Measurement of Inventories” (ASBJ Statement No. 9, July 4, 2019,
ASBJ)
・ “Accounting Standard for Financial Instruments” (ASBJ Statement No. 10, July 4, 2019, ASBJ)・ “Implementation Guidance on Accounting Standard for Fair Value Measurement (ASBJ
Guidance No. 31, July 4, 2019, ASBJ)
15

・ “Implementation Guidance on Disclosures about Fair Value of Financial Instruments (ASBJ
Guidance No. 19, March 31, 2020, ASBJ)
a. Overview
The International Accounting Standards Board (IASB) and the Financial Accounting Standards
Board (FASB) in the United States have established almost identical detailed guidance on fairvalue measurement (IFRS 13 “Fair Value Measurement” based on International Financial
Reporting Standards (IFRS) and Accounting Standards Codification Topic 820 “Fair Value
Measurement” based on U.S. generally accepted accounting principles (GAAP)). Considering thissituation, the Accounting Standards Board of Japan (ASBJ) has worked to ensure consistency
between Japanese standards primarily regarding guidance and disclosure related to the fair valueof financial instruments and international accounting standards, and has published the“Accounting Standards for Fair Value Measurement, etc.”
The basic policy of the ASBJ in developing accounting standards for fair value measurement is
to fundamentally incorporate all of the provisions of IFRS 13, from the standpoint of improving
the international comparability of financial statements between companies by applying a unified
measurement method, and to establish other accounting treatments for individual items without
significantly compromising comparability between financial statements, taking into consideration
practices, etc. that have been carried out in Japan.
b. Planned date of application
To be applied from the beginning of the fiscal year ending March 31, 2022
c. Impact of the application of the accounting standards, etc.
The Group is currently in the process of determining the effects of applying the AccountingStandards for Fair Value Measurement, etc. on the consolidated financial statements.
(3) Accounting Standard for Disclosure of Accounting Estimates“Accounting Standard for Disclosure of Accounting Estimates” (ASBJ Statement No. 31, March
31, 2020, ASBJ)
a. Overview
The International Accounting Standards Board (IASB) published International AccountingStandards (IAS) 1 “Presentation of Financial Statements” (“IAS 1”) in 2003, and paragraph 125of this standard requires the disclosure of “key sources of estimation uncertainty.” The ASBJ had
been requested to consider disclosure of this information as notes under Japanese generally
accepted accounting principles (GAAP), as this information would be highly useful to users offinancial statements. In response, the ASBJ has developed and published the Accounting Standard
for Disclosure of Accounting Estimates (“the Accounting Standard”).
The basic policy of the ASBJ in developing the Accounting Standard is not to enhance theinformation in individual notes, but to present the principles (the purpose of disclosure of key
sources of estimation uncertainty) and allow companies to determine the specific content of
disclosure in light of this purpose of disclosure. In developing the Accounting Standard, the ASBJ
16

referred to the provisions of paragraph 125 of IAS 1.
b. Planned date of application
To be applied from the close of the fiscal year ending March 31, 2021
(4) Accounting Standard for Accounting Policy Disclosures, Accounting Changes and Error
Corrections“Accounting Standard for Accounting Policy Disclosures, Accounting Changes and Error
Corrections” (ASBJ Statement No. 24, March 31, 2020, ASBJ)
a. Overview
The ASBJ received a recommendation to consider enhancing information in notes related to“principles and procedures of the accounting treatment adopted in cases where the provisions of
relevant accounting standards, etc. are unclear.” In response, the ASBJ made the necessary
revisions and published those revisions as part of the Accounting Standard for Accounting Policy
Disclosures, Accounting Changes and Error Corrections.
When enhancing the information in notes related to “principles and procedures of theaccounting treatment adopted in cases where the provisions of relevant accounting standards, etc.
are unclear,” the provisions of annotations (Note 1-2) will be carried over in order not to conflictwith the current accounting practices where the relevant accounting standards are clear.
b. Planned date of application
To be applied from the close of the fiscal year ending March 31, 2021
(Changes in Presentation Basis)(Consolidated Statements of Income)“Insurance claim income” was presented as a separate item under “Non-operating income” in theprevious fiscal year. However, in the fiscal year under review it has been included in “Other”
because the total amount of insurance claim income did not exceed 10% of the total amount of
non-operating income. The consolidated financial statements for the previous fiscal year havebeen restated to reflect this change in presentation.
As a result, ¥34 million recorded as “Insurance claim income” and ¥34 million recorded as“Other” under “Non-operating income” in the consolidated statement of income for the previous
fiscal year has been restated as “Other” of ¥69 million.

17

(Business Combinations)(Business divestiture of Nitta Casings Inc. and Nitta Casings (CANADA) Inc.)
1. Outline of Business Divestiture(1) Name of company that succeeded the divested business
Viscofan USA Inc.
Viscofan Canada Inc.
(2) Business description of divested businessa. Consolidated subsidiary: Nitta Casings Inc.
Business activities:
Production and sales of collagen casingb. Consolidated subsidiary: Nitta Casings (CANADA) Inc.
Business activities:
Production and sales of collagen casing(3) Primary reason for business divestiture
Nitta Gelatin is steadily advancing business strategies and moving ahead with selection andconcentration in core business areas as stated under its management policy. As part of thepolicy, Nitta Gelatin will focus on its core business areas and agreed to the share transfer after
deciding that it would be better for the enhancement of medium- to long-term corporate valueof both companies to promote the integration of Nitta Gelatin Inc. and Nitta Casings(CANADA) Inc. and Viscofan USA Inc. and Viscofan Canada Inc., which have expertise in
the casings business.
(4) Date of business divestiture
December 19, 2019 (date of implementation for transfer of shares)
September 30, 2019 (deemed date of sale)(5) Outline of the transaction including legal format
A share transfer in which consideration is received solely in assets such as cash
2. Outline of accounting treatment(1) Gain on transfer of business
Loss on sales of stocks of subsidiaries and associates ¥2,760 million(2) Appropriate book values of assets and liabilities of business transferred and major
components
Current assets¥1,460 million
Noncurrent assets¥1,709 million
Total assets¥3,169 million
Current liabilities¥641 million
Noncurrent liabilities¥1,206 million
Total liabilities¥1,847 million18(4) Accounting treatment
The differences between the consolidated carrying amount of Nitta Casings Inc. and Nitta
Casings (CANADA) Inc. and their respective sales prices were recorded as a loss on sales ofstocks of subsidiaries and associates under extraordinary losses.
3. Reporting segment in which the divested business was included
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,so there are no relevant items to disclose.
4. Estimated net sales and operating income attributable to the divested business recorded on the
consolidated statement of income for the period under review
Net sales¥2,226 million
Operating income (loss)(¥106) million(Business divestiture of Package Hongkong Limited and Beijing Qiushi Collagen Casing Co., Ltd.)
1. Outline of Business Divestiture(1) Name of company that succeeded the divested businessCasing Hongkong Limited(2) Business description of divested businessa. Consolidated subsidiary: Package Hongkong Limited
Business activities:
Intermediate holding company
b. Equity-method affiliate: Beijing Qiushi Collagen Casing Co., Ltd.
Business activities:
Production and sales of collagen casing(3) Primary reason for business divestiture
The joint venture Beijing Qiushi Collagen Casing Co., Ltd. was established with Beijing
Qiushi Agricultural Development Co., Ltd. and developed with the purpose of expanding
Nitta Gelatin’s collagen casing business in the China market. However, there are significant
disparities between Beijing Qiushi Agricultural Development Co., Ltd. and Nitta Gelatin interms of business policies going forward. Therefore, Package Hongkong Limited, the holding
company, will be transferred to Casing Hongkong Limited.
(4) Date of business divestiture
December 12, 2019 (date of implementation for transfer of shares)
September 30, 2019 (deemed date of sale)(5) Outline of the transaction including legal format
A share transfer in which consideration is received solely in assets such as cash
2. Outline of accounting treatment(1) Gain on transfer of business
19

Gain on sales of stocks of subsidiaries and associates: 6 million(Package Hongkong Limited)
Loss on sales of stocks of subsidiaries and associates: 28 million(Beijing Qiushi Collagen Casing Co., Ltd.)(2) Appropriate book values of assets and liabilities of business transferred and major
components
Current assets¥0 million
Noncurrent assets¥211 million
Total assets¥211 million
Current liabilities¥6 million
Total liabilities¥6 million(3) Accounting treatment
The differences between the consolidated carrying amounts of Package Hongkong Limited
and Beijing Qiushi Agricultural Development Co., Ltd. and their respective sales prices wererecorded as a gain on sales of stocks of subsidiaries and associates and a loss on sales ofstocks of subsidiaries and associates under extraordinary gains and losses.
3. Reporting segment in which the divested business was included
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,so there are no relevant items to disclose.
4. Estimated net sales and operating income attributable to the divested business recorded on the
consolidated statement of income for the period under review.
Disclose is omitted because the impact is negligible.

20

(Segment Information)a. Segment Information
Fiscal year ended March 31, 2019 (From April 1, 2018 to March 31, 2019)
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,
so information is omitted.
Fiscal year ended March 31, 2020 (From April 1, 2019 to March 31, 2020)
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,
so information is omitted.
b. Related information
Fiscal year ended March 31, 2019 (From April 1, 2018 to March 31, 2019)
1. Information by products and services
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting
segment, so information is omitted.
2. Information by countries and regions(1) Net sales(Millions of yen)

Japan

India

Asia

U.S.

Canada

Other

Total

19,764

2,593

2,324

9,632

1,688

460

36,464

Note: Sales are classified into countries or regions based on customers’ locations.

(2) Property, plant and equipment(Millions of yen)

Japan

India

3,628

3,219

Asia

U.S.

27

4,054

CanadaTotal

620

11,551

3. Information by main customer
The Company has omitted disclosure because no sales to any external customer exceeded 10%of the total net sales on the consolidated statements of income.
Fiscal year ended March 31, 2020 (From April 1, 2019 to March 31, 2020)
1. Information by products and services
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting
segment, so information is omitted.
2. Information by countries and regions(1) Net sales(Millions of yen)

Japan

India

Asia

U.S.

Canada

Other

Total

19,176

2,932

2,231

8,175

1,543

485

34,543

Note: Sales are classified into countries or regions based on customers’ locations.

21

(2) Property, plant and equipment(Millions of yen)

Japan

India

3,650

2,958

Asia

U.S.

30

2,052

Canada

Total

491

9,183

3. Information by main customer
The Company has omitted disclosure because no sales to any external customer exceeded 10%of the total net sales on the consolidated statements of income.
c. Information on impairment loss on noncurrent assets by reporting segments
Fiscal year ended March 31, 2019 (From April 1, 2018 to March 31, 2019)
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,
so information is omitted.
Fiscal year ended March 31, 2020 (From April 1, 2019 to March 31, 2020)
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,
so information is omitted.
d. Information on amortization of goodwill and unamortized amounts by reporting segments
Fiscal year ended March 31, 2019 (From April 1, 2018 to March 31, 2019)
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,
so information is omitted.
Fiscal year ended March 31, 2020 (From April 1, 2019 to March 31, 2020)
The Nitta Gelatin Group’s collagen business has become the Company’s only reporting segment,
so information is omitted.
e. Information on gain on negative goodwill by reporting segments
None.

(Per Share Information)
Fiscal 2019
(From April 1, 2018
to March 31, 2019)

Fiscal 2020
(From April 1, 2019
to March 31, 2020)

Net assets per share¥862.29¥852.71
Net income (loss) per share¥53.85(¥37.79)
Notes: 1. Diluted net income per share for fiscal 2019 is not disclosed due to the absence of latentshares with dilution effect.
2. Diluted net income per share for fiscal 2020 is not disclosed due to the recording of anet loss per share and the absence of latent shares with dilution effect.
3. Basis for calculating net income (loss) per share data is shown below.

22Fiscal 2019
(From April 1, 2018
to March 31, 2019)

Net income (loss) per share
Net income (loss) attributable to owners of
the parent (Millions of yen)(Amounts not attributable to commonshareholders (Millions of yen)
Net income (loss) attributable to owners of
the parent related to common stock(Millions of yen)
Average number of common shares during
the period (shares)

Fiscal 2020
(From April 1, 2019
to March 31, 2020)

989

(694)

-

-

989

(694)

18,373,812

18,373,810(Subsequent Events)(Purchase of treasury stock)
At a Board of Directors meeting held on March 27, 2020, the Company passed a resolution related
to the purchase of treasury stock based on Article 156 of the Companies Act as applied pursuant to
Article 165(3) of the same law, and implemented the purchase of treasury stock as follows:
1. Reason for the purchase of treasury stock
To strive to improve capital efficiency and return profits to shareholders, and implement flexible
capital policies in response to a changing management environment
2. Details of the purchase(1) Class of shares:
Nitta Gelatin common stock(2) Total number of shares to be purchased: Up to 370,000 shares(3) Total amount of stock purchase:
Up to ¥200 million(4) Purchase period:
April 1 to May 29, 2020
(5) Purchase method: Market purchase based on a discretionary account transaction
agreement pertaining to treasury shares to be acquired
3. Results of the purchase of treasury stock
As a result of a market purchase on the Tokyo Stock Exchange, the Company had purchased a
total of 299,300 shares of Nitta Gelatin common stock (total amount of stock purchase: ¥199
million) through to May 29, 2020 and has completed the purchase of treasury stock inaccordance with the aforementioned resolution.

23